ROYAL BANK OF CANADA - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 39 filers reported holding TRANSPHORM INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$8,000
+33.3%
3,523
+110.0%
0.00%
Q2 2023$6,0000.0%1,678
+15.6%
0.00%
Q1 2023$6,000
-70.0%
1,451
-59.0%
0.00%
Q4 2022$20,000
+1900.0%
3,543
+1179.1%
0.00%
Q3 2022$1,000277
+130.8%
0.00%
Q2 2022$0
-100.0%
120
-98.4%
0.00%
Q1 2022$54,0007,6690.00%
Other shareholders
TRANSPHORM INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,772,875$18,978,0005.90%
Worth Venture Partners, LLC 911,237$4,584,0002.81%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$114,060,0002.29%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,944$1,262,0001.37%
Soros Fund Management 673,991$3,390,0000.06%
Polar Asset Management Partners Inc. 709,700$3,570,0000.04%
AMERIPRISE FINANCIAL INC 3,805,595$19,142,0000.01%
Stratos Wealth Partners, LTD. 30,000$151,0000.00%
FMR LLC 886$4,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,801$54,0000.00%
View complete list of TRANSPHORM INC shareholders